![Yi Shan Li](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yi Shan Li
Fondateur chez
Blossomhill Therapeutics, Inc.
Profil
Yi Shan Li is the founder of Blossomhill Therapeutics, Inc., founded in 2020, holding the title of Executive Chairman since 2020.
Dr. Li was the founder of Turning Point Therapeutics, Inc., founded in 2013, and held the title Head-TP Therapeutics Asia in 2019.
Former jobs include Director at SABiosciences Corp.
from 2002 to 2009, Executive Vice President at Epitomics, Inc. from 2008 to 2013, Vice President at Kenson Ventures LLC from 2001 to 2003, Member at the University of California, Berkeley, Principal at RBC Capital Markets LLC, and Principal at Santa Cruz Biotechnology, Inc. Education history includes a doctorate from The Ohio State University conferred in 1994, an MBA from the University of California, Berkeley conferred in 2001, and an undergraduate degree from the University of Science & Technology of China conferred in 1987.
Postes actifs de Yi Shan Li
| Sociétés | Poste | Début |
|---|---|---|
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for oncology and autoimmune diseases | Fondateur | 01/06/2020 |
Anciens postes connus de Yi Shan Li
| Sociétés | Poste | Fin |
|---|---|---|
| TURG POIN | Directeur Général | 01/09/2018 |
Epitomics, Inc.
 Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody technology used for research and diagnostics | Corporate Officer/Principal | 30/04/2013 |
SABiosciences Corp.
 SABiosciences Corp. Medical SpecialtiesHealth Technology Develops and markets technologies for genetic and medical research | Directeur/Membre du Conseil | 31/12/2009 |
Kenson Ventures LLC
 Kenson Ventures LLC Investment ManagersFinance Kenson Ventures invests in companies located in the United States with an investment size from USD 0.5 - 3 million. The firm focuses on sectors such as biotechnology and life sciences. It participates in early and late-stage transactions. It also takes a seat on the board of directors. | Private Equity Investor | 31/12/2003 |
RBC Capital Markets LLC
 RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Formation de Yi Shan Li
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Epitomics, Inc.
Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody technology used for research and diagnostics | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RBC Capital Markets LLC
RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Kenson Ventures LLC
Kenson Ventures LLC Investment ManagersFinance Kenson Ventures invests in companies located in the United States with an investment size from USD 0.5 - 3 million. The firm focuses on sectors such as biotechnology and life sciences. It participates in early and late-stage transactions. It also takes a seat on the board of directors. | Finance |
Santa Cruz Biotechnology, Inc.
 Santa Cruz Biotechnology, Inc. BiotechnologyHealth Technology Provides primary antibodies and support products services | Health Technology |
University of Science & Technology of China
 University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SABiosciences Corp.
SABiosciences Corp. Medical SpecialtiesHealth Technology Develops and markets technologies for genetic and medical research | Health Technology |
Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for oncology and autoimmune diseases | Health Technology |
Choisissez Zonebourse 
